the present invention relates generally to the fields of pharmacology , and particularly to a method for treating inflammation , particularly inflammation of the respiratory system . the invention provides a method to reduce or ameliorate inflammation , by administering an effective amount of a protein factor originally isolated from thymic tissue , and referred to as t4 immune stimulating factor .